Rights and permissions
About this article
Cite this article
Adding enfuvirtide to HAART worth the extra cost. Pharmacoecon. Outcomes News 485, 10 (2005). https://doi.org/10.2165/00151234-200504850-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504850-00020